Molecular Pathogenesis of Pituitary Tumors

Ezzat, Shereen; Sylvia, L.

doi:10.1016/b978-0-12-801238-3.98872-x

Cited by 1 publication

(1 citation statement)

References 57 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Because of the complicated pathogenesis of PitNET, the risk factors were believed to include genetic events, hormonal stimulation, and growth factors in general. These three factors can promote tumor cell growth and proliferation 6 . The progression from PitNET to carcinoma is accompanied by cumulative changes in miRNA 7 ; however, mechanisms elucidating pituitary malignancy remain elusive.…”

Section: Introductionmentioning

confidence: 99%

MiRNA Signatures Related to Invasiveness and Recurrence in Patients With Non-Functioning Pituitary Neuroendocrine Tumors

Nikolova,

Nankova,

Kalenderova

et al. 2024

Exp Clin Endocrinol Diabetes

View full text Add to dashboard Cite

Purpose: The aim of this preliminary study was to analyze and identify differentially expressed miRNAs in Bulgarian patients with non-functioning pituitary neuroendocrine tumors (NFPitNET). The relationship between deregulated miRNAs and tumor invasiveness, recurrence, and size was determined. Methods: Twenty patients with non-functioning pituitary neuroendocrine tumors were selected and fresh pituitary tumor tissues were collected. RNA containing miRNAs were isolated using miRNAeasy mini kit and analysed with LNA miRNA Cancer Focus PCR Panel (Qiagen) by quantitative real-time PCR. Results: Three miRNAs (miR-210-3p, miR-149-3p and miR-29b-3p) were deregulated in invasive compared to non-invasive NFPitNETs. Differential expression of four-miRNA signature - miRNA-17, miR-19, miR-106a and miR-20, correlated with patient recurrence. Conclusion: In this pilot prospective study, we selected a unique miRNA expression profile that correlates with invasiveness and recurrence in non-functioning pituitary neuroendocrine tumors. Moreover, some of the selected miRNAs are reported for the first time in patients with this disease, shedding light on the molecular mechanisms involved in pituitary pathogenesis. The identified miRNAs demonstrate potential as biomarkers, deserving further investigation in a larger cohort to validate their clinical applicability.

show abstract

Section: Introductionmentioning

confidence: 99%